Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models.
Saved in:
| Title: | Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models. |
|---|---|
| Authors: | Koch MS; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Zdioruk M; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Nowicki MO; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Griffith AM; Harvard Medical School, Boston, Massachusetts, USA.; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Aguilar E; Candel Therapeutics, Needham, Massachusetts, USA., Aguilar LK; Candel Therapeutics, Needham, Massachusetts, USA., Guzik BW; Candel Therapeutics, Needham, Massachusetts, USA., Barone F; Candel Therapeutics, Needham, Massachusetts, USA., Tak PP; Candel Therapeutics, Needham, Massachusetts, USA., Tabatabai G; Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tuebingen, Tuebingen, Germany., Lederer JA; Harvard Medical School, Boston, Massachusetts, USA.; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Chiocca EA; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Lawler S; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA slawler@bwh.harvard.edu.; Harvard Medical School, Boston, Massachusetts, USA. |
| Source: | Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Jan; Vol. 10 (1). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!